The association between the BRI and all-cause and cardiovascular mortality in COPD patients

Riken Chen1, Yuli Cai1, Qinghua Chen1

  • 1The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524003, China.

BMC Pulmonary Medicine
|September 1, 2025
PubMed

Insights

The Body Roundness Index (BRI) is linked to higher mortality in chronic obstructive pulmonary disease (COPD) patients. Higher BRI scores indicate increased risk for all-cause and cardiovascular death in COPD.

Area of Science:

  • Pulmonary Medicine
  • Cardiology
  • Biostatistics

Background:

  • Waist circumference is associated with COPD exacerbations.
  • The prognostic value of Body Roundness Index (BRI) in COPD patients is not well understood.

Purpose of the Study:

  • To investigate the association between BRI and all-cause and cardiovascular mortality in COPD patients.
  • To evaluate BRI's predictive performance for mortality in this population.

Main Methods:

  • Analysis of 3,672 COPD participants from NHANES (1999-2018).
  • Utilized multivariable Cox proportional hazards models, Kaplan-Meier analysis, and restricted cubic spline analyses.
  • Assessed BRI's predictive accuracy using ROC curves and conducted subgroup analyses.

Main Results:

  • BRI was significantly associated with increased all-cause and cardiovascular mortality.
  • Higher BRI quartiles correlated with reduced survival and increased cumulative mortality.
  • BRI demonstrated superior predictive performance for mortality compared to other models.

Conclusions:

  • BRI is a significant predictor of mortality in COPD patients.
  • Elevated BRI is linked to higher risks of all-cause and cardiovascular death.
  • BRI may serve as a target for interventions to reduce mortality in COPD.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305